Puma Biotechnology (NASDAQ:PBYI) reported quarterly earnings of $0.19 per share which beat the analyst consensus estimate of $0.04 by 375 percent. This is a 26.67 percent increase over earnings of $0.15 per share from the same period last year. The company reported quarterly sales of $53.600 million which beat the analyst consensus estimate of $53.000 million by 1.13 percent. This is a 8.94 percent increase over sales of $49.200 million the same period last year.